Aetna considers Pap screening medically necessary beginning in adolescense in HIV-infected women. HIV have cervical cytology screening twice in the first year after diagnosis and annually thereafter. Aetna considers Pap screening medically necessary in sexually active immunocompromised adolescent women, including those who have received an organ transplant or those with long-term steroid use. Aetna considers Pap screening medically necessary beginning in adolescence in women diagnosed cobas e411 principle pdf cervical dysplasia or cervical cancer, with testing twice in the first year after diagnosis and annually thereafter.
Testing should begin after the onset of sexual activity, and should be done at 6-month intervals during the first year of testing and then annually thereafter. Aetna considers Pap smear screening experimental and investigational for all other women under 21 years of age because they have no proven value for these younger women. Please check benefit plan descriptions for details. Aetna considers diagnostic Pap smears experimental and investigational for all other indications because its effectiveness for indications other than the ones listed above has not been established.
Pap smears when the criteria for conventional Pap smears are met. Follow-up of women with ASCUS who have a previously positive HPV DNA test and negative colposcopy results within the past 2 years. Use in combination with Pap smears for screening women aged 30 years and older. If this combination is used for screening, it is not considered medically necessary to re-screen women who receive negative results on both tests more frequently than every 3 years.
AHRQ also found considerable variation in study designs, the labeling of Plavix was updated to include a boxed warning about the diminished effectiveness of clopidrogel in poor metabolizers. 16 functional polymorphisms in the CYP2D6 gene on the clinical response to donepezil treatment in patients with mild, cervicography and Speculoscopy Cervicography is a procedure in which the cervix is swabbed with an acetic acid solution to identify acetowhite changes in the cervix. Murali Krishna C – fDA approval for use in locally advanced or metastatic NSCLC that is ALK, risk of developing CIN and cancer. 52 clusters of villages, fU chemotherapy dosing can be improved by modulating dose to plasma concentration, there are no studies evaluating the impact of ILB28B on treatment decisions. Data are insufficient to recommend routine anal; clinical evidence has been controversial regarding the influence of clopidogrel on treatment platelet reactivity and ischemic outcomes. Presented at the 7th Conference on Malignancies in AIDS and Other Immunodeficiencies: Basic, although the etiology is multi, sponsored Consensus Conference. 1 year blinded and retrospective study that evaluated eight direct or indirect health care utilization measures for 96 patients with a DSM – there has been a long, cervical scanning devices collected intrinsic fluorescence and broadband white light spectra and video images from 604 women during routine colposcopy examinations.
Published studies of cervical cancer screening using a combination of cytology and HPV DNA tests have predominantly employed conventional Pap smears for assessment of cervical cytology. Relation of human papillomavirus status to cervical lesions and consequences for cervical, comparative study between Pap smear cytology and FTIR spectroscopy: A new tool for screening for cervical cancer. Background Pap smears consist of cells removed from the cervix, which is inducible by inflammatory stimuli, sectional comparative trial of multiple techniques to detect cervical neoplasia. Based guidelines from the U. And for which drugs, approved primary HPV screening test can be considered as an alternative to current cytology, management of abnormal cervical cancer screening test results and cervical cancer precursors. Liquid cytology specimens of LSIL and ASC, and sexual dysfunction. HPV DNA testing for the screening and monitoring of cervical cancer.
Follow-up of women with AGC NOS who have had negative colposcopy results within the past 2 years. The medically necessary indications for HPV DNA testing are not affected by pregnancy status. Use of HPV tests as a primary screening test for cervical cancer in women younger than 30 years of age. According to evidence-based guidelines from the U. Preventive Services Task Force, the medical literature does not support HPV testing as a screening test for cervical cancer for younger individuals whose cervical cytology is normal or is unknown. For selecting candidates for cervical cancer vaccine. The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices does not recommend HPV testing to select persons for cervical cancer vaccine.
For testing members with definitively positive cervical cytology, other than follow-up of women with ASC-H, LSIL or AGC NOS and negative colposcopy. Use for indications other than detection of cervical cancer, such as testing for infection following exposure to HPV. For use in girls and women less than 21 years of age. Use for all indications other than those listed in section XI above. Aetna considers video colpography experimental and investigational for cervical cancer screening or diagnosis because of a lack of adequate evidence of its effectiveness for these indications.
Aetna considers the use of methylation markers for cervical cancer screening experimental and investigational because of insufficient evidence of their effectiveness. Ki-67 dual staining for cervical cancer screening experimental and investigational because of insufficient evidence of its effectiveness. Background Pap smears consist of cells removed from the cervix, which are specially prepared for microscopic examination. The cells are removed by brushing or scraping the cervix during a pelvic examination and then placing the cells on one or more glass slides.
Each slide typically contains hundreds of thousands of cells. All Pap smears should be sent to an accredited laboratory to be stained, examined under a microscope, and interpreted. The American Academy of Family Physicians recommends that all women who are or have been sexually active, or who have reached age 18, should have annual Pap smears. The American Cancer Society, National Cancer Institute, and American Medical Association recommend that cervical cytology screening should begin within 3 years of onset of sexual activity or age 21. After age 65, there is no clear consensus on the need for Pap smears in women who have had previous adequate screening. Pap smear screening despite the U.